Three Decades announces completion of a new round of strategic financing

robot
Abstract generation in progress
Mars Finance News, July 13: Tridic (Nanjing) Pharmaceutical Technology Co., Ltd. (referred to as “Tridic”) announced the completion of a new round of strategic financing. Investors include Shanghai Minhang District Financial Investment Development Co., Ltd., Shanghai Lingang Digital Technology Private Fund Management Co., Ltd., and others. Yibo served as the sole exclusive financial advisor for this round. The new strategic financing will be used to build the Shanghai International R&D and production center, to advance clinical development of the oral polypeptide pipeline, and to expand international cooperation business. In addition, Hangzhou Industrial Investment Group Co., Ltd. also participated in this transaction and plans to further discuss with the company additional directions for strategic cooperation. (Chuangtoujia CLUB)
View Original
This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.
  • Reward
  • Comment
  • Repost
  • Share
Comment
Add a comment
Add a comment
No comments
  • Pinned